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We studied 78 patients with Lyme disease to determine how immune complexes and autoan-
tibodies are related to the development of chronic Lyme arthritis. Circulating Clq binding
material was found in nearly all patients at onset oferythema chronicum migrans, the skin le-
sion that marks the onset of infection with the causative spirochete. In patients with only
subsequent arthritis this material tended to localize to joints where it gradually increased in
concentrations with greater duration of joint inflammation. In joints, its concentration cor-
related positively with the number ofsynovial fluid polymorphonuclear leukocytes. Despitethe
prolonged presence of putative immune complexes, rheumatoid factors could not be demon-
strated. These observations suggest that phlogistic immune complexes based on spirochete
antigens form locally within joints during chronic Lyme arthritis.
Lyme disease is the result of an infection with a spirochete [1,2]. The ability to
identify the organism, to date its time of entry, to observe a persistent arthritis, and
to treat the pre-articular phase with an effective antibiotic provide a unique oppor-
tunity to examine questions that are important in a number of major rheumatic ill-
nesses. We have used this disease as a model for studying mechanisms of chronic
joint inflammation. Because rheumatoid arthritis may be caused by an as yet elusive
infectious agent, we have been particularly interested in whether Lyme arthritis re-
quires the continued presence of the spirochete in viable form or only substances
derived from it, or, alternatively, involves self-perpetuating mechanisms that the
spirochete sets in motion but which remain active long after it is gone. The present
study grew out of an effort to identify pathophysiological processes in Lyme ar-
thritis that might fall into the latter category.
METHODS
Patients were diagnosed as having Lyme disease as described previously [3]. They
were examined as soon as possible after the onset of erythema chronicum migrans
(ECM) and at one-week to four-week intervals during symptomatic periods. At the
end of a minimum of 12 months follow-up each patient was assigned to one ofthree
categories: "skin alone" if only ECM had occurred; "arthritis" if objective arthritis
had occurred with or without ECM; or "nerve or heart" if neurologic or cardiac in-
volvement was documented. Remission was defined as no signs or symptoms for at
least two weeks.
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Blood and synovial fluid samples obtained during routine phlebotomies and ar-
throcentecies were allowed to clot at room temperature for two hours, centrifuged,
and the recovered fluids were stored at -70°C until tested in the 1251-Clq binding
assay [4]. The amounts of radiolabeled Clq bound by patient sera were compared
with that bound by a panel of normal sera: the mean and standard deviations (SD)
ofthe binding exhibited by ten rLormal sera were calculated, and patient and control
sera were compared in terms ofmultiples ofthis SD. Test serawith reactivity greater
than 2 SD above the mean of normal were considered positive [4].
Synovial fluid white blood cell counts were performed in the clinical laboratories
of the Yale-New Haven Medical Center. Sera were tested for cold reactive rheuma-
toid factors as described previously [5].
RESULTS
We studied 78 patients with Lyme disease, including 48 individuals with arthritis
and 14 with nerve or heart involvement. The clinical features of these patients have
been described previously [6]. As illustrated in Fig. 1, circulating Clq binding
material was present in serum from nearly all patients tested during the first two
weeks after onset of ECM. While this material usually persisted in patients with
nerve or heart involvement, it tended to disappear in patients with only arthritis and
was absent in patients with sustained remission.
It is important to note that detection ofthe Clq reactive material in these patients
required careful handling of their sera. The ability of sera to bind Clq was reduced
or abolished by repeated freezing or thawing or overnight exposure to room
temperature. When sera were handled as described above, most of the positive pa-
tients had test results that were 2-6 SD units above the mean of normals with little
variation in reactivity during storage periods of up to two years.
We previously observed that Clq binding material may be present in synovial
fluid during attacks of arthritis even when it is absent from the circulation [6]. This
observation suggested that the immune complexes of Lyme arthritis may be formed
locally within joints. Consequently we studied 11 patients prospectively (including
six who were studied serially) to determine ifClq binding material was related to the
duration of joint involvement. As shown in Fig. 2, the reactivity of synovial fluid
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tended to rise progressively with increasing duration of arthritis. Synovial fluid Clq
binding activity was found to correlate directly with the number of polymor-
phonuclear leukocytes in synovial fluid (Fig. 3). In contrast, no relationship was ob-
served between Clq binding and synovial fluid content of total hemolytic comple-
ment, or complement components C3 and C4.
We observed previously that nearly all patients with Lyme disease have negative
latex agglutination tests [3] and lack IgG class rheumatoid factors [4]. Moreover,
tests for antinuclear antibodies have rarely been positive [7]. These observations
have led us to hypothesize that autoantibodies do not appear in the course of Lyme
disease. As a further test of this idea, sera from twenty patients with Lyme arthritis
were tested for cold reactive rheumatoid factors using IgG coated latex particles as
described in patients with mononucleosis [5]. Negative results were obtained in every
case.
DISCUSSION
It is now clear that the Lyme disease spirochete is present in skin at the time of
ECM and in CSF during meningoencephalitis [1]. These phases of the disease are
usually accompanied by Clq binding material in the circulation. In contrast, in pa-
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tients with arthritis alone, the whereabouts of the spirochete is uncertain and im-
mune complexes are often localized to joints, suggesting that they are being formed
locally, possibly in response to spirochetal antigens [6]. It is not yet known whether
antibiotic therapy universally cures chronic Lyme arthritis. When this question is
answered, it should be clear whether the mechanisms responsible for the synovitis
are dependent on viable spirochetes.
The present study provides further evidence that immune complexes have an ac-
tive role in the pathophysiology ofLyme arthritis. They increase in concentration as
the arthritis becomes more chronic and they correlate with the concentration of
polymorphonuclear leukocytes in synovial fluid. In addition, aggregates of IgG and
IgM have been observed in polymorphonuclear leukocytes isolated from synovial
fluid of patients with Lyme disease [Newman J: unpublished data). Thus, the intra-
articular immune complexes of Lyme disease appear to be involved in at least two
central mechanisms of inflammation-generation ofleukotactic stimuli and phago-
cytosis-that can potentially contribute to tissue injury.
Although Lyme disease resembles rheumatoid arthritis in the apparent intra-
articular formation of immune complexes, the two diseases differ markedly with
respect to the occurrence of autoantibodies. For example, in rheumatoid arthritis a
variety of autoantibodies are recognized, including rheumatoid factors, antinuclear
antibodies, and antibodies against collagen. Theoretically, these autoantibodies
might serve to perpetuate joint inflammation even in the absence of the original
causative agent [8]. It has been shown that both immune complexes and a polypep-
tide derived from the Fc region of IgG are powerful mitogens which can stimulate
antibody production by B lymphocytes [9,10]. One can then imagine apositive feed-
back system in which lymphoid cells in the synovium secrete autoantibodies into the
closedjoint space where they bind their antigens (themselves, nuclear debris, and so
on) and subsequently give rise to diffusable products that in turn stimulate yet
another round of autoantibody production. It may be important that granulocyte
elastase can cleave immunoglobulin to release the mitogenic Fc fragments [11].
We have been unable to detect an increased incidence of autoantibodies in Lyme
disease and mechanisms such as those noted above can not be implicated in this
disorder at the present time. Thus, continued immune system activity such as the
characteristic prolonged elevation of IgM [12,13] may simply reflect persisting
spirochetal antigens.
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